Oxford Instruments PLC Disposal of OI Healthcare business in the US (8244D)
24 Febbraio 2020 - 08:00AM
UK Regulatory
TIDMOXIG
RNS Number : 8244D
Oxford Instruments PLC
24 February 2020
Oxford Instruments plc
Disposal of OI Healthcare business in the United States
Oxford, 24 February 2020
Oxford Instruments plc, a leading provider of high technology
products and services to industrial companies and scientific
research communities, today announces that it has completed the
sale of its OI Healthcare business in the US to MXR Imaging, Inc,
for a consideration of $15.0 million (GBP11.5 million).
The OI Healthcare business in the US offers the sale, service
and rental of third-party Magnetic Resonance Imaging and Computer
Tomography machines, with offices in Florida, Michigan and
California.
Ian Barkshire, Chief Executive of Oxford Instruments said, "The
sale of the Oxford Instruments' US-based OI Healthcare business
further supports our ongoing strategy to focus on chosen markets
with long-term growth drivers where we can uphold or develop
leading positions. This sale will allow us to continue enhancing
our ability to deliver further growth and margin improvement while
maintaining a customer-centric approach."
-END-
Enquiries:
Oxford Instruments plc Tel: 01865 393200
Ian Barkshire, Chief Executive
Gavin Hill, Group Finance Director
MHP Communications Tel: 020 3128 8100
Rachel Hirst/Alice McLaren
- Ends -
Issued for and on behalf of Oxford Instruments plc
Notes to Editors
About Oxford Instruments plc
Oxford Instruments designs, supplies and supports
high-technology tools and systems with a focus on research and
industrial applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for 60 years,
supporting its core purpose to address some of the world's most
pressing challenges.
The first technology business to be spun out from Oxford
University, Oxford Instruments is now a global company and is
listed on the London Stock Exchange (OXIG). Its strategy focuses on
being a customer-centric, market-focused Group, understanding the
technical and commercial challenges faced by its customers. Key
market segments include Semiconductor & Communications,
Advanced Materials, Healthcare & Life Science, and Quantum
Technology.
Their portfolio includes a range of core technologies in areas
such as low temperature and high magnetic field environments;
Nuclear Magnetic Resonance; X-ray, electron, laser and optical
based metrology; atomic force microscopy; optical imaging; and
advanced growth, deposition and etching.
Oxford Instruments is helping enable a greener economy,
increased connectivity, improved health and leaps in scientific
understanding. Their advanced products and services allow the
world's leading industrial companies and scientific research
communities to image, analyse and manipulate materials down to the
atomic and molecular level, helping to accelerate R&D, increase
manufacturing productivity and make ground breaking
discoveries.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DISKKNBBKBKBDBB
(END) Dow Jones Newswires
February 24, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Oxford Instruments (LSE:OXIG)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Oxford Instruments (LSE:OXIG)
Storico
Da Mar 2023 a Mar 2024